

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Renal cell carcinoma: a review of biology and... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-307/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-307" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Renal cell carcinoma: a review of biology and pathophysiology" />
    
            <meta name="og:title" content="F1000Research Article: Renal cell carcinoma: a review of biology and pathophysiology.">
            <meta name="og:description" content="Read the latest article version by Shahzaib Nabi, Elizabeth R. Kessler, Brandon Bernard, Thomas W. Flaig, Elaine T. Lam, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="14298">
            <meta name="article-id" content="13179">
            <meta name="dc.title" content="Renal cell carcinoma: a review of biology and pathophysiology">
            <meta name="dc.description" content="Over the past decade, our understanding of the biology and pathophysiology of renal cell carcinoma (RCC) has improved significantly. Insight into the disease process has helped us in developing newer therapeutic approaches toward RCC. In this article, we review the various genetic and immune-related mechanisms involved in the pathogenesis and development of this cancer and how that knowledge is being used to develop therapeutic targeted drugs for the treatment of RCC. The main emphasis of this review article is on the most common genetic alterations found in clear cell RCC and how various drugs are currently targeting such pathways. This article also looks at the role of the immune system in allowing the growth of RCC and how the immune system can be manipulated to reactivate cytotoxic immunity against RCC.">
            <meta name="dc.subject" content="renal cell carcinoma, biology, von Hippel Lindau, VHL, PBRM-1, BAP-1, HIF, mTOR, Glutaminase, Immunotherapy">
            <meta name="dc.creator" content="Nabi, Shahzaib">
            <meta name="dc.creator" content="Kessler, Elizabeth R.">
            <meta name="dc.creator" content="Bernard, Brandon">
            <meta name="dc.creator" content="Flaig, Thomas W.">
            <meta name="dc.creator" content="Lam, Elaine T.">
            <meta name="dc.date" content="2018/03/12">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.13179.1">
            <meta name="dc.source" content="F1000Research 2018 7:307">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="renal cell carcinoma">
            <meta name="prism.keyword" content="biology">
            <meta name="prism.keyword" content="von Hippel Lindau">
            <meta name="prism.keyword" content="VHL">
            <meta name="prism.keyword" content="PBRM-1">
            <meta name="prism.keyword" content="BAP-1">
            <meta name="prism.keyword" content="HIF">
            <meta name="prism.keyword" content="mTOR">
            <meta name="prism.keyword" content="Glutaminase">
            <meta name="prism.keyword" content="Immunotherapy">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/03/12">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="307">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.13179.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-307">
            <meta name="citation_title" content="Renal cell carcinoma: a review of biology and pathophysiology">
            <meta name="citation_abstract" content="Over the past decade, our understanding of the biology and pathophysiology of renal cell carcinoma (RCC) has improved significantly. Insight into the disease process has helped us in developing newer therapeutic approaches toward RCC. In this article, we review the various genetic and immune-related mechanisms involved in the pathogenesis and development of this cancer and how that knowledge is being used to develop therapeutic targeted drugs for the treatment of RCC. The main emphasis of this review article is on the most common genetic alterations found in clear cell RCC and how various drugs are currently targeting such pathways. This article also looks at the role of the immune system in allowing the growth of RCC and how the immune system can be manipulated to reactivate cytotoxic immunity against RCC.">
            <meta name="citation_description" content="Over the past decade, our understanding of the biology and pathophysiology of renal cell carcinoma (RCC) has improved significantly. Insight into the disease process has helped us in developing newer therapeutic approaches toward RCC. In this article, we review the various genetic and immune-related mechanisms involved in the pathogenesis and development of this cancer and how that knowledge is being used to develop therapeutic targeted drugs for the treatment of RCC. The main emphasis of this review article is on the most common genetic alterations found in clear cell RCC and how various drugs are currently targeting such pathways. This article also looks at the role of the immune system in allowing the growth of RCC and how the immune system can be manipulated to reactivate cytotoxic immunity against RCC.">
            <meta name="citation_keywords" content="renal cell carcinoma, biology, von Hippel Lindau, VHL, PBRM-1, BAP-1, HIF, mTOR, Glutaminase, Immunotherapy">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Shahzaib Nabi">
            <meta name="citation_author_institution" content="Division of Medical Oncology, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA">
            <meta name="citation_author" content="Elizabeth R. Kessler">
            <meta name="citation_author_institution" content="Division of Medical Oncology, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA">
            <meta name="citation_author" content="Brandon Bernard">
            <meta name="citation_author_institution" content="Division of Medical Oncology, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA">
            <meta name="citation_author" content="Thomas W. Flaig">
            <meta name="citation_author_institution" content="Division of Medical Oncology, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA">
            <meta name="citation_author" content="Elaine T. Lam">
            <meta name="citation_author_institution" content="Division of Medical Oncology, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA">
            <meta name="citation_publication_date" content="2018/03/12">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="307">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.13179.1">
            <meta name="citation_firstpage" content="307">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-307/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-307.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=14298 /> <input type=hidden id=articleId name=articleId value=13179 /> <input type=hidden id=xmlUrl value="/articles/7-307/v1/xml"/> <input type=hidden id=xmlFileName value="-7-307-v1.xml"> <input type=hidden id=article_uuid value=d5cea59e-f882-409f-84b9-c52f6def71df /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Renal cell carcinoma: a review of biology and pathophysiology"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.13179.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.13179.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-307"
  },
  "headline": "Renal cell carcinoma: a review of biology and pathophysiology",
  "datePublished": "2018-03-12T13:48:51",
  "dateModified": "2018-03-12T13:48:51",
  "author": [
    {
      "@type": "Person",
      "name": "Shahzaib Nabi"
    },    {
      "@type": "Person",
      "name": "Elizabeth R. Kessler"
    },    {
      "@type": "Person",
      "name": "Brandon Bernard"
    },    {
      "@type": "Person",
      "name": "Thomas W. Flaig"
    },    {
      "@type": "Person",
      "name": "Elaine T. Lam"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Over the past decade, our understanding of the biology and pathophysiology of renal cell carcinoma (RCC) has improved significantly. Insight into the disease process has helped us in developing newer therapeutic approaches toward RCC. In this article, we review the various genetic and immune-related mechanisms involved in the pathogenesis and development of this cancer and how that knowledge is being used to develop therapeutic targeted drugs for the treatment of RCC. The main emphasis of this review article is on the most common genetic alterations found in clear cell RCC and how various drugs are currently targeting such pathways. This article also looks at the role of the immune system in allowing the growth of RCC and how the immune system can be manipulated to reactivate cytotoxic immunity against RCC."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-307.html",
            "name": "Renal cell carcinoma: a review of biology and pathophysiology"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Renal cell carcinoma: a review of biology and pathophysiology </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=14298 data-id=13179 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13179.1" data-recommended="" data-doi="10.12688/f1000research.13179.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-307/v1/pdf?article_uuid=d5cea59e-f882-409f-84b9-c52f6def71df" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-13179-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-13179-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-13179-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Nabi S, Kessler ER, Bernard B <em>et al.</em> Renal cell carcinoma: a review of biology and pathophysiology [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):307 (<a class=new-orange href="https://doi.org/10.12688/f1000research.13179.1" target=_blank>https://doi.org/10.12688/f1000research.13179.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-13179-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=13179 id=track-article-signin-13179 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13179?target=/articles/7-307.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=14298 /> <input name=articleId type=hidden value=13179 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Renal cell carcinoma: a review of biology and pathophysiology</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Shahzaib Nabi,&nbsp;</span><span class="">Elizabeth R. Kessler,&nbsp;</span><span class="">Brandon Bernard,&nbsp;</span><span class="">Thomas W. Flaig,&nbsp;</span><span class=""><a href="mailto:elaine.lam@ucdenver.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Elaine T. Lam</span></a><a href="https://orcid.org/0000-0001-5629-3402" target=_blank id=author-orcid-4><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-4><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5629-3402</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Shahzaib Nabi,&nbsp;</span><span class="">Elizabeth R. Kessler,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Brandon Bernard,&nbsp;</span><span class="">Thomas W. Flaig,&nbsp;</span><span class=""><a href="mailto:elaine.lam@ucdenver.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Elaine T. Lam</span></a><a href="http://orcid.org/0000-0001-5629-3402" target=_blank id=mauthor-orcid-4><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-4><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5629-3402</div></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 12 Mar 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.13179.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Division of Medical Oncology, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA<br/> <p> <div class=margin-bottom> Shahzaib Nabi <br/> <span>Roles: </span> Conceptualization, Project Administration, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Elizabeth R. Kessler <br/> <span>Roles: </span> Conceptualization, Writing  Review & Editing </div> <div class=margin-bottom> Brandon Bernard <br/> <span>Roles: </span> Conceptualization, Writing  Review & Editing </div> <div class=margin-bottom> Thomas W. Flaig <br/> <span>Roles: </span> Conceptualization, Writing  Review & Editing </div> <div class=margin-bottom> Elaine T. Lam <br/> <span>Roles: </span> Conceptualization, Project Administration, Resources, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=31549-31649></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=31548-31650></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Over the past decade, our understanding of the biology and pathophysiology of renal cell carcinoma (RCC) has improved significantly. Insight into the disease process has helped us in developing newer therapeutic approaches toward RCC. In this article, we review the various genetic and immune-related mechanisms involved in the pathogenesis and development of this cancer and how that knowledge is being used to develop therapeutic targeted drugs for the treatment of RCC. The main emphasis of this review article is on the most common genetic alterations found in clear cell RCC and how various drugs are currently targeting such pathways. This article also looks at the role of the immune system in allowing the growth of RCC and how the immune system can be manipulated to reactivate cytotoxic immunity against RCC. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> renal cell carcinoma, biology, von Hippel Lindau, VHL, PBRM-1, BAP-1, HIF, mTOR, Glutaminase, Immunotherapy </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Elaine T. Lam (<a href="mailto:elaine.lam@ucdenver.edu">elaine.lam@ucdenver.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Elaine T. Lam </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> ETL receives kidney cancer clinical trial funding from Argos, Bristol-Myers Squibb, Calithera, Genentech, Merck, Peloton, Pfizer, and Roche; has served as a consultant for Bristol-Myers Squibb; and serves on the Independent Data Monitoring Board for Calithera. ERK receives kidney cancer clinical trial funding from Bristol-Myers Squibb. TWF receives clinical trial funding from Bristol-Myers Squibb, Novartis, Pfizer, Bavarian Nordic, Cougar Biotechnology, Dendreon, GTx, Janssen Oncology, Medivation, Sanofi, Genentech, Roche, Exelixis, Aragon Pharmaceuticals, Sotio, Tokai Pharmaceuticals, Astra-Zeneca/MedImmune, Lilly, Astellas, Agensys, and Seattle Genetics and has served as a consultant for GTx. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> ETL receives funding support from the National Institutes of Health/National Cancer Institute Paul Calabresi Award in Clinical Oncology Research (K12CA086913). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Nabi S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Nabi S, Kessler ER, Bernard B <em>et al.</em> Renal cell carcinoma: a review of biology and pathophysiology [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):307 (<a href="https://doi.org/10.12688/f1000research.13179.1" target=_blank>https://doi.org/10.12688/f1000research.13179.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 12 Mar 2018, <b>7</b>(F1000 Faculty Rev):307 (<a href="https://doi.org/10.12688/f1000research.13179.1" target=_blank>https://doi.org/10.12688/f1000research.13179.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 12 Mar 2018, <b>7</b>(F1000 Faculty Rev):307 (<a href="https://doi.org/10.12688/f1000research.13179.1" target=_blank>https://doi.org/10.12688/f1000research.13179.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d10e204>Introduction</h2><p class="" id=d10e207>Renal cell carcinoma (RCC) is a heterogeneous group of cancers arising from renal tubular epithelial cells that encompasses 85% of all primary renal neoplasms<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. The most common subtypes of RCC are clear cell RCC (ccRCC), papillary RCC, and chromophobe RCC<sup><a href="#ref-1">1</a></sup>. The remaining 15% of tumors of the kidney consist of transitional cell carcinoma (8%), nephroblastoma or Wilms tumor (56%), collecting duct tumors (&lt;1%), renal sarcomas (&lt;1%), and renal medullary carcinomas (&lt;1%). The incidence of RCC varies widely in different parts of the world, and the highest incidences are in North America and the Czech Republic<sup><a href="#ref-2">2</a></sup>. In the US, there are 64,000 new cases of RCC and 14,000 RCC-related deaths each year<sup><a href="#ref-3">3</a></sup>. Age, race, and gender also play a role in this disease. RCC is more common in males above the age of 60 (median age for RCC is 65), and the highest incidence is in the sixth to eighth decades of life<sup><a href="#ref-4">4</a></sup>. Within the US, Caucasians, African-Americans, Hispanics, and Native Americans have a higher incidence of RCC as compared with Asian-Americans or Pacific Islanders<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>.</p><p class="" id=d10e241>Multiple risk factors for RCC along with their pathophysiologic mechanisms have been described. These include both genetic and acquired risk factors. The two most common genes involved in the pathogenesis of RCC are the Von HippelLindau (<i>VHL</i>) gene and the protein polybromo-1 (<i>PBRM-1</i>) gene. These will be discussed separately in this article. The most common acquired risk factors for RCC are smoking, hypertension, obesity, chronic analgesic use, and diabetes<sup><a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10e257>Genetic alterations in renal cell carcinoma</h2><p class="" id=d10e260>The most common genetic alteration associated with the development of ccRCC is loss of the short arm of chromosome 3 (loss of 3p). This alteration is seen in approximately 95% of cases of ccRCC. The most common genes involved in the pathogenesis of ccRCC include <i>VHL</i>, <i>PBRM-1</i>, <i>SETD2</i>, <i>BAP-1</i>, <i>KDM5C</i>, and <i>MTOR</i><sup><a href="#ref-1">1</a>,<a href="#ref-8">8</a></sup>. Other genetic alterations include gain of 5q (69%), partial loss of 14q (42%), 7q gain (20%), 8p deletion (32%), and 9p loss (29%)<sup><a href="#ref-8">8</a></sup>.</p><div class=section><a name=d10e292 class=n-a></a><h3 class=section-title>Von HippelLindau gene</h3><p class="" id=d10e297> <i>VHL</i> is a tumor suppressor gene that plays a pivotal role in the development of ccRCC. <i>VHL</i> can be altered and transmitted in an autosomal dominant fashion (VHL disease) or in a sporadic manner. Although inherited VHL disease is rare, understanding the molecular basis of VHL disease and the identification of the VHL suppressor gene have provided great insight into the pathogenesis of sporadic disease. It is estimated that 5060% of patients with sporadic ccRCC have an abnormality of the <i>VHL</i> gene<sup><a href="#ref-9">9</a><a href="#ref-11">11</a></sup>. Other, more sophisticated studies have suggested that <i>VHL</i> gene alterations through genetic and epigenetic mechanisms can be found in up to 90% of ccRCC cases<sup><a href="#ref-12">12</a></sup>.</p><p class="" id=d10e324>A two-hit hypothesis has been described and validated in patients with VHL disease-related development of RCC (and other tumors). Based on this hypothesis, individuals with VHL disease are born with one inactivated copy of the <i>VHL</i> gene in all cells while the other copy of the gene is normal.For tumorigenesis to take place, there must be a loss of function of the second gene copy as well. This second hit usually takes place as a result of somatic mutation or deletion of the allele. In patients with sporadic RCC, inactivation of both VHL alleles usually takes place via somatic mutations.</p><p class="" id=d10e330>The product of the <i>VHL</i> gene is a protein called pVHL, which acts as a tumor suppressor protein. VHL protein forms complexes with several other proteins in the cell, including elongin B, elongin C, and cellulin 2. The resulting complex (called the VBC complex) helps in the proteasomal degradation of several intracellular proteins. One of the major functions of the VHL gene product is regulating the levels of several intracellular proteins, including hypoxia-inducible factor 1 alpha and 2 alpha (HIF1A and HIF2A)<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. These intracellular proteins, when bound with each other, serve as transcription factors by binding to the DNA, resulting in upregulation of messenger RNA (mRNA) that codes for several growth factors, including vascular endothelial growth factor (VEGF), platelet-derived growth factor beta (PDGFB), and transforming growth factor alpha (TGFA). These growth factors play a vital role in the development of highly vascular tumors (such as ccRCC) associated with <i>VHL</i> gene alterations. The mRNA also codes for other proteins and enzymes responsible for controlling proteins in the extracellular matrix.</p><p class="" id=d10e346>Under normal oxygen tension, HIF1A and HIF2A are hydroxylated on proline residues and bind the pVHL, resulting in polyubiquitination of HIFA, which targets it for proteasomal degradation (<a href="#f1">Figure 1</a>)<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. Under conditions of hypoxemia or in the absence of pVHL, hydroxylation of HIF1A and HIF2A does not occur and HIFA accumulates in the cell and dimerizes with hypoxia-inducible factor beta (HIFB). The HIFAHIFB complex then migrates to the nucleus and acts as a transcription factor, resulting in increased mRNA levels coding for VEGF, PDGFB, TGFA, erythropoietin, and extracellular matrix proteins<sup><a href="#ref-14">14</a>,<a href="#ref-17">17</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/14298/8bacbf22-4079-407e-8945-a7e8d5b8a810_figure1.gif"><img alt="8bacbf22-4079-407e-8945-a7e8d5b8a810_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/14298/8bacbf22-4079-407e-8945-a7e8d5b8a810_figure1.gif"></a><div class=caption><h3>Figure 1. VHL/HIF axis.</h3><p id=d10e377>Under normal oxygen tension, HIF1A and HIF2A are hydroxylated on proline residues and bind the pVHL, resulting in the polyubiquitination of HIFA, which targets it for proteasomal degradation. Under conditions of hypoxemia or in the absence of pVHL, hydroxylation of HIF1A and HIF2A does not occur and HIFA accumulates and dimerizes with HIFB and acts as a transcription factor, resulting in increased mRNA levels coding for VEGF, PDGFB, TGFA, erythropoietin, and extracellular matrix protein. HIFA, hypoxia-inducible factor alpha; HIFB, hypoxia-inducible factor beta; MMP, matrix metalloproteinase protein; mRNA, messenger RNA; PDGFB, platelet-derived growth factor beta; pVHL, protein of Von HippelLindau gene; TGFA, transforming growth factor alpha; VEGF, vascular endothelial growth factor.</p></div></div><p class="" id=d10e384>From a therapeutic standpoint, inhibitors of VEGF are typically used as first-line therapy for the treatment of metastatic ccRCC. Sunitinib and pazopanib are two commonly used tyrosine kinase inhibitors that target and block vascular epidermal growth factor receptor (VEGFR)<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. Axitinib, cabozantinib, lenvatinib, and sorafenib are other tyrosine kinase inhibitors that block VEGFR. Bevacizumab, a monoclonal antibody that directly targets VEGF, is also a treatment option for ccRCC. In addition, drugs that block HIFA would theoretically block this pathway, resulting in a decrease in the production of angiogenic factors (such as VEGF and PDGFB) and a decrease in tumor growth. Selective HIF2 antagonists PT2399, PT2385, and PT2977 are under investigation<sup><a href="#ref-20">20</a><a href="#ref-22">22</a></sup>. PT2399 has been shown to cause regression in preclinical models (cell line and tumorgraft/patient-derived xenograft) of pVHL-defective ccRCC<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. PT2385 has been evaluated as monotherapy in a phase 1 study in patients with metastatic ccRCC and has been shown to have a favorable safety profile and early evidence of efficacy<sup><a href="#ref-22">22</a></sup>. PT2977, a more potent HIF2a antagonist, is being investigated in phase 1 clinical trials for the treatment of solid tumors and ccRCC and in a phase 2 clinical trial for the treatment of patients with VHL disease.</p></div><div class=section><a name=d10e413 class=n-a></a><h3 class=section-title>Protein polybromo-1 gene</h3><p class="" id=d10e418> <i>PBRM-1</i> is also a tumor suppressor gene that plays an important role in the pathogenesis of ccRCC. It encodes a protein called BAF180, which is a subunit of the nucleosome remodeling complex. The nucleosome remodeling complex is a complex group of proteins that control the expression of certain genes by accessing the condensed part of the DNA. It is unclear how BAF180 acts as a tumor suppressor protein; however, several animal studies have shown that it plays a role in controlling the cell cycle and replicative senescence. Re-introduction of <i>PBRM-1</i> in <i>PBRM-1</i>-deficient cell lines typically produces cell cycle arrest. Thus, a mutated <i>PBRM-1</i> gene would result in an abnormal/malfunctioning BAF180, which would result in unchecked cell growth and subsequent tumorigenesis<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>.</p></div><div class=section><a name=d10e441 class=n-a></a><h3 class=section-title>BRCA1-associated protein-1</h3><p class="" id=d10e446>BRCA1-associated protein-1 (<i>BAP-1</i>) is a tumor suppressor gene located on 3p. This gene is mutated in approximately 15% of ccRCC cases. <i>BAP-1</i>-mutated tumors tend to be more aggressive and are generally related to a worse prognosis<sup><a href="#ref-25">25</a></sup>. Like other tumor suppressor genes, <i>BAP-1</i> plays a role in the suppression of cell proliferation. It does so by interacting with a transcription protein called host cell factor-1 (HCF-1). HCF-1 in turn binds with several transcription factors, resulting in the inhibition of cell proliferation. A mutated BAP-1 protein is unable to interact with HCF-1; as a result, the inhibitory effects of HCF-1 on cell proliferation are lost<sup><a href="#ref-26">26</a></sup>.</p></div><div class=section><a name=d10e468 class=n-a></a><h3 class=section-title>The mTOR pathway</h3><p class="" id=d10e473>The mammalian target of rapamycin (mTOR) is a protein kinase that is encoded by the <i>MTOR</i> gene. It plays an important role in the regulation of the cell cycle and has been a therapeutic target of interest in many other cancers as well. The mTORPI3K pathway starts with the binding of several growth factors to the cell surface, resulting in the activation of phosphatidylinositol-3-kinase (PI3K) protein (<a href="#f2">Figure 2</a>). Activated PI3K in turn activates mTOR, creating mTOR complexes 1 and 2 (mTORC1 and mTORC2), which lead to the phosphorylation of P70S6K and 4E-BP1/eukaryotic translation initiation factor 4E (4E-BP1/eIF4E). The phosphorylated P70SK migrates to the nucleus and initiates the transcription of mRNA coding for the HIFA protein, which, as mentioned above, has the ability to increase the production of angiogenic proteins such as VEGF, PDGF, and TGFB<sup><a href="#ref-27">27</a><a href="#ref-29">29</a></sup>. Phosphorylation of the translational regulator eIF4E-binding protein 1 (4E-BP1) also mediates the effects of oncogenic Akt signaling on mRNA translation, cell growth, and tumor progression<sup><a href="#ref-29">29</a></sup>.</p><a name=f2 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/14298/8bacbf22-4079-407e-8945-a7e8d5b8a810_figure2.gif"><img alt="8bacbf22-4079-407e-8945-a7e8d5b8a810_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/14298/8bacbf22-4079-407e-8945-a7e8d5b8a810_figure2.gif"></a><div class=caption><h3>Figure 2. The mTORPI3K pathway.</h3><p id=d10e503>Binding of cell surface growth factors activates phosphatidylinositol-3-kinase (PI3K) protein, which in turn activates mTOR, creating mTOR complexes 1 and 2 (mTORC1 and mTORC2), resulting in the phosphorylation of P70S6K and 4E-BP1/eIF4E and increased production of angiogenic proteins such as VEGF, PDGF, and TGFB, leading to cell growth and tumor progression.</p><p id=d10e506>4E-BP1, 4E-binding protein 1; eIF-4E, eukaryotic initiation factor-4E; HIF, hypoxia-inducible factor; HIFA, hypoxia-inducible factor alpha; MMP, matrix metalloproteinase; mRNA, messenger RNA; mTOR, mammalian target of rapamycin; PDGFB, platelet-derived growth factor beta; PI3K, phosphatidylinositol-3-kinase; PKB, protein kinase B; TGFA, transforming growth factor alpha; VEGF, vascular endothelial growth factor.</p></div></div><p class="" id=d10e513>Everolimus and temsirolimus are mTOR inhibitors that are approved for the treatment of metastatic ccRCC<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>. Additionally, the combination of lenvatinib (VEGFR inhibitor) and everolimus (mTOR inhibitor) has been approved for the treatment of metastatic RCC in the second- and subsequent-line setting.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10e527>The role of the immune system in renal cell carcinoma</h2><p class="" id=d10e530>The cytotoxic component of the immune system plays a vital role in the recognition and subsequent rejection of several different types of cancer, including RCC. Unfortunately, this innate system is not always adequate in attacking and eliminating cancer. In order to survive the immune response, the cancer cells develop certain proteins on their cell surface, which help them fight off the cytotoxic T cells by certain pathways. One such pathway is the programmed death-1 (PD-1) pathway.</p><p class="" id=d10e533>Under normal circumstances, the cytotoxic immune system is designed to recognize the foreign antigens present on the surface of cancer cells. This should lead to the activation of cytotoxic T lymphocytes, resulting in the release of cytokines such as interferons, interleukin-2, and tumor necrosis factor. These cytokines are directly responsible for the death of cancer cells. From a therapeutic standpoint, both interferon-alpha and interleukin-2 have historically been used for the treatment of ccRCC, although their use has diminished with the advent of effective and better-tolerated alternatives<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. Immune T-cell infiltration is a prevalent characteristic of ccRCCs and represents an important target for immune checkpoint inhibitor therapy<sup><a href="#ref-1">1</a>,<a href="#ref-34">34</a></sup>.</p><div class=section><a name=d10e550 class=n-a></a><h3 class=section-title>The programmed death-1 receptor pathway</h3><p class="" id=d10e555>The PD-1 receptor is a cell membrane protein present on the surface of cytotoxic T lymphocytes (CD8 T cells). The proteins that activate PD-1 are also cell surface proteins called programmed death ligand-1 and -2 (PD-L1 and PD-L2). PD-L1 is present on the surface of antigen-presenting cells and certain malignant cells, including RCC cells. The major function of PD-1, after being activated by binding PD-L1, is to suppress the cytotoxic immune system by inducing apoptosis of the cytotoxic T lymphocyte. This normally prevents an uncontrolled and unchecked autoimmune response when the body is exposed to a foreign antigen (such as a virus or bacterium). Thus, PD-1 is an anti-immune protein, the stimulation of which suppresses the immune system and decreases the number of cytotoxic T cells attacking foreign antigens and cancer cells (<a href="#f3">Figure 3</a>).</p><a name=f3 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/14298/8bacbf22-4079-407e-8945-a7e8d5b8a810_figure3.gif"><img alt="8bacbf22-4079-407e-8945-a7e8d5b8a810_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/14298/8bacbf22-4079-407e-8945-a7e8d5b8a810_figure3.gif"></a><div class=caption><h3>Figure 3. The programmed death-1 receptor pathway.</h3><p id=d10e571>Recognition of foreign or tumor antigens normally results in the activation of CD8 T cells, leading to the killing of viruses or bacteria or the lysis of tumor cells. The programmed death-1 (PD-1) receptor is a cell membrane protein present on the surface of CD8 T cells, which, upon interacting with PD-L1 and PD-L2 on the surface of tumor cells, results in the suppression of the cytotoxic immune response, leading to tumor escape.IFN, interferon; IL-2, interleukin-2; MHC, major histocompatibility complex; PD-1, programmed death-1; PD-L1, programmed death ligand-1; TCR, T-cell receptor.</p></div></div><p class="" id=d10e578>Several cancers, including ccRCC, express PD-L1 on their surface. The expression of PD-L1 allows these cancers to escape the cytotoxic immune response by inducing the apoptosis of cytotoxic T lymphocytes. This discovery has led to the development of antibodies that target and block PD-1 and PD-L1. The PD-1-blocking antibodies currently available are nivolumab and pembrolizumab. Nivolumab is currently approved for the treatment of metastatic ccRCC in the second-line setting<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. Atezolizumab and avelumab are PD-L1-blocking monoclonal antibodies that are also under investigation for metastatic ccRCC.</p><p class="" id=d10e588>CTLA-4 is a protein receptor present on the surface of cytotoxic T lymphocytes, and the primary function is downregulation of the immune system (similar to the PD-1/PD-L1 pathway) but by a different mechanism. An inhibitor of this receptor, called ipilimumab, in combination with PD-1/PD-L1 inhibitors, is under investigation and has shown promising results for the treatment of metastatic RCC<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d10e596>OX-40 is another pro-inflammatory protein present on the surface of cytotoxic T lymphocytes. The stimulation of this receptor results in the activation of the immune system (similar to that seen with PD-1/PD-L1 inhibition). OX-40 agonists in combination with PD-1 inhibitors are under investigation for the treatment of RCC<sup><a href="#ref-38">38</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10e607>Metabolic pathways and targets in renal cell carcinoma</h2><p class="" id=d10e610>Altered metabolic pathways in cancer cells play a key role in their survival. These pathways also help cancer cells escape different levels of stress imposed on them by the immune system as well as various drugs. Targeting various metabolic pathways in RCC is an active area of research in oncology<sup><a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>.</p><div class=section><a name=d10e620 class=n-a></a><h3 class=section-title>The glutaminase pathway</h3><p class="" id=d10e625>Glutamine is an important amino acid in many cancer cells (including ccRCC cells) and is indirectly required by these cells for the synthesis of DNA. Cancer cells metabolize glutamine differently than do normal cells and require an enzyme called glutaminase. This enzyme converts glutamine to glutamate, which in turn increases the production of aspartate through the Krebs cycle. Aspartate plays a key role in the synthesis of pyrimidines in these cells and is required for maturation. In <i>VHL</i>-mutated/-deficient cells, glutamine is also required for the synthesis of essential lipids, citrate, and glutathione, the latter of which is the key anti-oxidant molecule generated by cells to combat oxidative stress<sup><a href="#ref-41">41</a></sup>. Therefore, inhibition of this pathway results in both cell cycle arrest (by decreasing pyrimidine synthesis required for DNA formation) and an inability of these cells to fight oxidative stress. These findings have led to the development of drugs targeting this pathway, which are under investigation. For example, CB-839 is a glutaminase inhibitor that is being studied in clinical trials for several solid tumors, including ccRCC<sup><a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup>.</p></div><div class=section><a name=d10e643 class=n-a></a><h3 class=section-title>Other metabolic pathways and targets</h3><p class="" id=d10e648>Glucose metabolism in cancer cells is also an area of clinical interest in this field. GLUT-1 is a glucose transporter that is responsible for the uptake of glucose by RCC cells. Several drugs blocking this transporter have been shown to be active in RCC<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. Studies have demonstrated that, unlike in normal cells, glycolysis is the major source of glucose in cancer cells, even in the presence of sufficient oxygen (aerobic glycolysis)<sup><a href="#ref-46">46</a></sup>. As a result, several inhibitors of glycolytic enzymes have been investigated because of their activity in cancer cells, including RCC cells<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. Similarly, pyruvate dehydrogenase inhibitors have shown activity in preclinical RCC xenografts<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>.</p></div><div class=section><a name=d10e677 class=n-a></a><h3 class=section-title>Other novel approaches and combinations</h3><p class="" id=d10e682>Despite our extensive knowledge and understanding of the biology of this cancer, metastatic RCC continues to lead to a high number of deaths in the modern era. With the discovery of pathways outlined in this article, many research studies are now geared toward combining drugs that target different pathways in ccRCC. Combination studies in metastatic ccRCC that pair VEGF inhibition and checkpoint inhibition include bevacizumab plus atezolizumab, axitinib plus pembrolizumab, and nivolumab plus ipilimumab plus cabozantinib. There are also studies of combination immunotherapies targeting PD-1 and PD-L1 or targeting PD-L1 and OX40.</p><p class="" id=d10e685>In addition, the glutaminase inhibitor CB-839 is being investigated in combination with anti-PD-1 antibody nivolumab as well as with the mTOR inhibitor everolimus and the VEGFR/MET inhibitor cabozantinib in separate clinical trials.</p><p class="" id=d10e688>A better understanding of the biology and pathogenesis of ccRCC has revolutionized the treatment approach. Novel targets and combination strategies are under investigation with the hope of achieving longer and more durable responses and improving survival.</p><p class="" id=d10e691>In summary, with a greater understanding of the pathogenesis of RCC, many therapeutic advances for metastatic disease have been introduced in the last decade. Such progress has led to improved survival for patients with advanced RCC. Much of the recent therapeutic development has focused on inhibition of the VEGFR and the mTOR pathways. Current and ongoing areas of research include the additional development of new immunotherapy targets, metabolic targeting, and combinational approaches to treat the disease.</p></div></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d10e1 class=n-a></a><h2 class=main-title id=d186>Competing interests</h2><p class=metadata-entry><a name=d10e136 class=n-a></a><p id=d10e137> ETL receives kidney cancer clinical trial funding from Argos, Bristol-Myers Squibb, Calithera, Genentech, Merck, Peloton, Pfizer, and Roche; has served as a consultant for Bristol-Myers Squibb; and serves on the Independent Data Monitoring Board for Calithera. ERK receives kidney cancer clinical trial funding from Bristol-Myers Squibb. TWF receives clinical trial funding from Bristol-Myers Squibb, Novartis, Pfizer, Bavarian Nordic, Cougar Biotechnology, Dendreon, GTx, Janssen Oncology, Medivation, Sanofi, Genentech, Roche, Exelixis, Aragon Pharmaceuticals, Sotio, Tokai Pharmaceuticals, Astra-Zeneca/MedImmune, Lilly, Astellas, Agensys, and Seattle Genetics and has served as a consultant for GTx.</p></p></div><div class=back-section><a name=d10e1 class=n-a></a><h2 class=main-title id=d188>Grant information</h2><p>ETL receives funding support from the National Institutes of Health/National Cancer Institute Paul Calabresi Award in Clinical Oncology Research (K12CA086913).</p><p><i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d10e699 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d362>References</h2><div class="section ref-list"><a name=d10e699 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732090639"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e706 class=n-a></a>Hsieh JJ, Purdue MP, Signoretti S, <i> et al.</i>: Renal cell carcinoma. <i>Nat Rev Dis Primers.</i> 2017; <b>3</b>: 17009. <a target=xrefwindow id=d10e717 href="http://www.ncbi.nlm.nih.gov/pubmed/28276433">PubMed Abstract </a> | <a target=xrefwindow id=d10e720 href="http://dx.doi.org/10.1038/nrdp.2017.9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732090639">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d10e733 class=n-a></a>Chow WH, Dong LM, Devesa SS: Epidemiology and risk factors for kidney cancer. <i>Nat Rev Urol.</i> 2010; <b>7</b>(5): 24557. <a target=xrefwindow id=d10e741 href="http://www.ncbi.nlm.nih.gov/pubmed/20448658">PubMed Abstract </a> | <a target=xrefwindow id=d10e744 href="http://dx.doi.org/10.1038/nrurol.2010.46">Publisher Full Text </a> | <a target=xrefwindow id=d10e747 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3012455">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727169355"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e756 class=n-a></a>Siegel RL, Miller KD, Jemal A: Cancer Statistics, 2017. <i>CA Cancer J Clin.</i> 2017; <b>67</b>(1): 730. <a target=xrefwindow id=d10e764 href="http://www.ncbi.nlm.nih.gov/pubmed/28055103">PubMed Abstract </a> | <a target=xrefwindow id=d10e767 href="http://dx.doi.org/10.3322/caac.21387">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727169355">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d10e780 class=n-a></a>Thompson RH, Ordonez MA, Iasonos A, <i> et al.</i>: Renal cell carcinoma in young and old patients--is there a difference? <i>J Urol.</i> 2008; <b>180</b>(4): 12626; discussion 1266. <a target=xrefwindow id=d10e791 href="http://www.ncbi.nlm.nih.gov/pubmed/18707708">PubMed Abstract </a> | <a target=xrefwindow id=d10e794 href="http://dx.doi.org/10.1016/j.juro.2008.06.037">Publisher Full Text </a> | <a target=xrefwindow id=d10e798 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2615196">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d10e807 class=n-a></a>Siegel R, Ward E, Brawley O, <i> et al.</i>: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. <i>CA Cancer J Clin.</i> 2011; <b>61</b>(4): 21236. <a target=xrefwindow id=d10e818 href="http://www.ncbi.nlm.nih.gov/pubmed/21685461">PubMed Abstract </a> | <a target=xrefwindow id=d10e821 href="http://dx.doi.org/10.3322/caac.20121">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717989833"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e831 class=n-a></a>Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. <i>CA Cancer J Clin.</i> 2012; <b>62</b>(1): 1029. <a target=xrefwindow id=d10e839 href="http://www.ncbi.nlm.nih.gov/pubmed/22237781">PubMed Abstract </a> | <a target=xrefwindow id=d10e842 href="http://dx.doi.org/10.3322/caac.20138">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717989833">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d10e855 class=n-a></a>Motzer RJ, Jonasch E, Agarwal N, <i> et al.</i>: Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. <i>J Natl Compr Canc Netw.</i> 2017; <b>15</b>(6): 80434. <a target=xrefwindow id=d10e866 href="http://www.ncbi.nlm.nih.gov/pubmed/28596261">PubMed Abstract </a> | <a target=xrefwindow id=d10e869 href="http://dx.doi.org/10.6004/jnccn.2017.0100">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d10e878 class=n-a></a>Beroukhim R, Brunet JP, Di Napoli A, <i> et al.</i>: Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. <i>Cancer Res.</i> 2009; <b>69</b>(11): 467481. <a target=xrefwindow id=d10e889 href="http://www.ncbi.nlm.nih.gov/pubmed/19470766">PubMed Abstract </a> | <a target=xrefwindow id=d10e892 href="http://dx.doi.org/10.1158/0008-5472.CAN-09-0146">Publisher Full Text </a> | <a target=xrefwindow id=d10e896 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2745239">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d10e905 class=n-a></a>Foster K, Prowse A, van den Berg A, <i> et al.</i>: Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. <i>Hum Mol Genet.</i> 1994; <b>3</b>(12): 216973. <a target=xrefwindow id=d10e916 href="http://www.ncbi.nlm.nih.gov/pubmed/7881415">PubMed Abstract </a> | <a target=xrefwindow id=d10e919 href="http://dx.doi.org/10.1093/hmg/3.12.2169">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d10e928 class=n-a></a>Gnarra JR, Tory K, Weng Y, <i> et al.</i>: Mutations of the VHL tumour suppressor gene in renal carcinoma. <i>Nat Genet.</i> 1994; <b>7</b>(1): 8590. <a target=xrefwindow id=d10e939 href="http://www.ncbi.nlm.nih.gov/pubmed/7915601">PubMed Abstract </a> | <a target=xrefwindow id=d10e942 href="http://dx.doi.org/10.1038/ng0594-85">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d10e951 class=n-a></a>Yao M, Yoshida M, Kishida T, <i> et al.</i>: VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma. <i>J Natl Cancer Inst.</i> 2002; <b>94</b>(20): 156975. <a target=xrefwindow id=d10e962 href="http://www.ncbi.nlm.nih.gov/pubmed/12381710">PubMed Abstract </a> | <a target=xrefwindow id=d10e965 href="http://dx.doi.org/10.1093/jnci/94.20.1569">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d10e975 class=n-a></a>Nickerson ML, Jaeger E, Shi Y, <i> et al.</i>: Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. <i>Clin Cancer Res.</i> 2008; <b>14</b>(15): 472634. <a target=xrefwindow id=d10e986 href="http://www.ncbi.nlm.nih.gov/pubmed/18676741">PubMed Abstract </a> | <a target=xrefwindow id=d10e989 href="http://dx.doi.org/10.1158/1078-0432.CCR-07-4921">Publisher Full Text </a> | <a target=xrefwindow id=d10e993 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2629664">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d10e1002 class=n-a></a>Kaelin WG Jr: Molecular basis of the VHL hereditary cancer syndrome. <i>Nat Rev Cancer.</i> 2002; <b>2</b>(9): 67382. <a target=xrefwindow id=d10e1010 href="http://www.ncbi.nlm.nih.gov/pubmed/12209156">PubMed Abstract </a> | <a target=xrefwindow id=d10e1013 href="http://dx.doi.org/10.1038/nrc885">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d10e1022 class=n-a></a>Barry RE, Krek W: The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis. <i>Trends Mol Med.</i> 2004; <b>10</b>(9): 46672. <a target=xrefwindow id=d10e1030 href="http://www.ncbi.nlm.nih.gov/pubmed/15350900">PubMed Abstract </a> | <a target=xrefwindow id=d10e1033 href="http://dx.doi.org/10.1016/j.molmed.2004.07.008">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d10e1042 class=n-a></a>Kim WY, Kaelin WG: Role of <i>VHL</i> gene mutation in human cancer. <i>J Clin Oncol.</i> 2004; <b>22</b>(24): 49915004. <a target=xrefwindow id=d10e1053 href="http://www.ncbi.nlm.nih.gov/pubmed/15611513">PubMed Abstract </a> | <a target=xrefwindow id=d10e1056 href="http://dx.doi.org/10.1200/JCO.2004.05.061">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d10e1065 class=n-a></a>Pugh CW, Ratcliffe PJ: Regulation of angiogenesis by hypoxia: role of the HIF system. <i>Nat Med.</i> 2003; <b>9</b>(6): 67784. <a target=xrefwindow id=d10e1073 href="http://www.ncbi.nlm.nih.gov/pubmed/12778166">PubMed Abstract </a> | <a target=xrefwindow id=d10e1076 href="http://dx.doi.org/10.1038/nm0603-677">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d10e1085 class=n-a></a>Maxwell PH, Pugh CW, Ratcliffe PJ: Activation of the HIF pathway in cancer. <i>Curr Opin Genet Dev.</i> 2001; <b>11</b>(3): 2939. <a target=xrefwindow id=d10e1093 href="http://www.ncbi.nlm.nih.gov/pubmed/11377966">PubMed Abstract </a> | <a target=xrefwindow id=d10e1096 href="http://dx.doi.org/10.1016/S0959-437X(00)00193-3">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1088476"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1106 class=n-a></a>Motzer RJ, Hutson TE, Tomczak P, <i> et al.</i>: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. <i>N Engl J Med.</i> 2007; <b>356</b>(2): 11524. <a target=xrefwindow id=d10e1117 href="http://www.ncbi.nlm.nih.gov/pubmed/17215529">PubMed Abstract </a> | <a target=xrefwindow id=d10e1120 href="http://dx.doi.org/10.1056/NEJMoa065044">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1088476">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718083271"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1133 class=n-a></a>Motzer RJ, Hutson TE, Cella D, <i> et al.</i>: Pazopanib versus sunitinib in metastatic renal-cell carcinoma. <i>N Engl J Med.</i> 2013; <b>369</b>(8): 72231. <a target=xrefwindow id=d10e1144 href="http://www.ncbi.nlm.nih.gov/pubmed/23964934">PubMed Abstract </a> | <a target=xrefwindow id=d10e1147 href="http://dx.doi.org/10.1056/NEJMoa1303989">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718083271">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726713697"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1160 class=n-a></a>Chen W, Hill H, Christie A, <i> et al.</i>: Targeting renal cell carcinoma with a HIF-2 antagonist. <i>Nature.</i> 2016; <b>539</b>(7627): 1127. <a target=xrefwindow id=d10e1171 href="http://www.ncbi.nlm.nih.gov/pubmed/27595394">PubMed Abstract </a> | <a target=xrefwindow id=d10e1174 href="http://dx.doi.org/10.1038/nature19796">Publisher Full Text </a> | <a target=xrefwindow id=d10e1178 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5340502">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726713697">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726730699"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1191 class=n-a></a>Cho H, Du X, Rizzi JP, <i> et al.</i>: On-target efficacy of a HIF-2 antagonist in preclinical kidney cancer models. <i>Nature.</i> 2016; <b>539</b>(7627): 10711. <a target=xrefwindow id=d10e1202 href="http://www.ncbi.nlm.nih.gov/pubmed/27595393">PubMed Abstract </a> | <a target=xrefwindow id=d10e1205 href="http://dx.doi.org/10.1038/nature19795">Publisher Full Text </a> | <a target=xrefwindow id=d10e1209 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5499381">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726730699">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d10e1222 class=n-a></a>Courtney KD, Infante JR, Lam ET, <i> et al.</i>: Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2 Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma. <i>J Clin Oncol.</i> 2017; JCO2017742627. <a target=xrefwindow id=d10e1230 href="http://www.ncbi.nlm.nih.gov/pubmed/29257710">PubMed Abstract </a> | <a target=xrefwindow id=d10e1233 href="http://dx.doi.org/10.1200/JCO.2017.74.2627">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d10e1242 class=n-a></a>Thompson M: Polybromo-1: the chromatin targeting subunit of the PBAF complex. <i>Biochimie.</i> 2009; <b>91</b>(3): 30919. <a target=xrefwindow id=d10e1250 href="http://www.ncbi.nlm.nih.gov/pubmed/19084573">PubMed Abstract </a> | <a target=xrefwindow id=d10e1253 href="http://dx.doi.org/10.1016/j.biochi.2008.10.019">Publisher Full Text </a> | <a target=xrefwindow id=d10e1256 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2646799">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d10e1266 class=n-a></a>Brugarolas J: PBRM1 and BAP1 as novel targets for renal cell carcinoma. <i>Cancer J.</i> 2013; <b>19</b>(4): 32432. <a target=xrefwindow id=d10e1274 href="http://www.ncbi.nlm.nih.gov/pubmed/23867514">PubMed Abstract </a> | <a target=xrefwindow id=d10e1277 href="http://dx.doi.org/10.1097/PPO.0b013e3182a102d1">Publisher Full Text </a> | <a target=xrefwindow id=d10e1280 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4222578">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d10e1289 class=n-a></a>Kapur P, Pea-Llopis S, Christie A, <i> et al.</i>: Effects on survival of <i>BAP1</i> and <i>PBRM1</i> mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. <i>Lancet Oncol.</i> 2013; <b>14</b>(2): 15967. <a target=xrefwindow id=d10e1307 href="http://www.ncbi.nlm.nih.gov/pubmed/23333114">PubMed Abstract </a> | <a target=xrefwindow id=d10e1310 href="http://dx.doi.org/10.1016/S1470-2045(12)70584-3">Publisher Full Text </a> | <a target=xrefwindow id=d10e1313 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4674067">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d10e1321 class=n-a></a>Pea-Llopis S, Vega-Rubn-de-Celis S, Liao A, <i> et al.</i>: BAP1 loss defines a new class of renal cell carcinoma. <i>Nat Genet.</i> 2012; <b>44</b>(7): 7519. <a target=xrefwindow id=d10e1332 href="http://www.ncbi.nlm.nih.gov/pubmed/22683710">PubMed Abstract </a> | <a target=xrefwindow id=d10e1335 href="http://dx.doi.org/10.1038/ng.2323">Publisher Full Text </a> | <a target=xrefwindow id=d10e1339 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3788680">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d10e1348 class=n-a></a>Zoncu R, Efeyan A, Sabatini DM: mTOR: from growth signal integration to cancer, diabetes and ageing. <i>Nat Rev Mol Cell Biol.</i> 2011; <b>12</b>(1): 2135. <a target=xrefwindow id=d10e1356 href="http://www.ncbi.nlm.nih.gov/pubmed/21157483">PubMed Abstract </a> | <a target=xrefwindow id=d10e1359 href="http://dx.doi.org/10.1038/nrm3025">Publisher Full Text </a> | <a target=xrefwindow id=d10e1362 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3390257">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d10e1371 class=n-a></a>Zarogoulidis P, Lampaki S, Turner JF, <i> et al.</i>: mTOR pathway: A current, up-to-date mini-review (Review). <i>Oncol Lett.</i> 2014; <b>8</b>(6): 236770. <a target=xrefwindow id=d10e1382 href="http://www.ncbi.nlm.nih.gov/pubmed/25360163">PubMed Abstract </a> | <a target=xrefwindow id=d10e1385 href="http://dx.doi.org/10.3892/ol.2014.2608">Publisher Full Text </a> | <a target=xrefwindow id=d10e1389 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4214394">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d10e1398 class=n-a></a>Laplante M, Sabatini DM: mTOR signaling in growth control and disease. <i>Cell.</i> 2012; <b>149</b>(2): 27493. <a target=xrefwindow id=d10e1406 href="http://www.ncbi.nlm.nih.gov/pubmed/22500797">PubMed Abstract </a> | <a target=xrefwindow id=d10e1409 href="http://dx.doi.org/10.1016/j.cell.2012.03.017">Publisher Full Text </a> | <a target=xrefwindow id=d10e1412 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3331679">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1120519"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1422 class=n-a></a>Motzer RJ, Escudier B, Oudard S, <i> et al.</i>: Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. <i>Lancet.</i> 2008; <b>372</b>(9637): 44956. <a target=xrefwindow id=d10e1433 href="http://www.ncbi.nlm.nih.gov/pubmed/18653228">PubMed Abstract </a> | <a target=xrefwindow id=d10e1436 href="http://dx.doi.org/10.1016/S0140-6736(08)61039-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1120519">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d10e1449 class=n-a></a>Rini BI, Bellmunt J, Clancy J, <i> et al.</i>: Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial. <i>J Clin Oncol.</i> 2014; <b>32</b>(8): 7529. <a target=xrefwindow id=d10e1460 href="http://www.ncbi.nlm.nih.gov/pubmed/24297945">PubMed Abstract </a> | <a target=xrefwindow id=d10e1463 href="http://dx.doi.org/10.1200/JCO.2013.50.5305">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d10e1472 class=n-a></a>Klapper JA, Downey SG, Smith FO, <i> et al.</i>: High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. <i>Cancer.</i> 2008; <b>113</b>(2): 293301. <a target=xrefwindow id=d10e1483 href="http://www.ncbi.nlm.nih.gov/pubmed/18457330">PubMed Abstract </a> | <a target=xrefwindow id=d10e1486 href="http://dx.doi.org/10.1002/cncr.23552">Publisher Full Text </a> | <a target=xrefwindow id=d10e1490 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3486432">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d10e1499 class=n-a></a>Fyfe G, Fisher RI, Rosenberg SA, <i> et al.</i>: Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. <i>J Clin Oncol.</i> 1995; <b>13</b>(3): 68896. <a target=xrefwindow id=d10e1510 href="http://www.ncbi.nlm.nih.gov/pubmed/7884429">PubMed Abstract </a> | <a target=xrefwindow id=d10e1513 href="http://dx.doi.org/10.1200/JCO.1995.13.3.688">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726994979"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1522 class=n-a></a>enbabaolu Y, Gejman RS, Winer AG, <i> et al.</i>: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. <i>Genome Biol.</i> 2016; <b>17</b>(1): 231. <a target=xrefwindow id=d10e1533 href="http://www.ncbi.nlm.nih.gov/pubmed/27855702">PubMed Abstract </a> | <a target=xrefwindow id=d10e1536 href="http://dx.doi.org/10.1186/s13059-016-1092-z">Publisher Full Text </a> | <a target=xrefwindow id=d10e1540 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5114739">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726994979">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725252542"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1553 class=n-a></a>Motzer RJ, Rini BI, McDermott DF, <i> et al.</i>: Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. <i>J Clin Oncol.</i> 2015; <b>33</b>(13): 14307. <a target=xrefwindow id=d10e1564 href="http://www.ncbi.nlm.nih.gov/pubmed/25452452">PubMed Abstract </a> | <a target=xrefwindow id=d10e1567 href="http://dx.doi.org/10.1200/JCO.2014.59.0703">Publisher Full Text </a> | <a target=xrefwindow id=d10e1571 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4806782">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725252542">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d10e1585 class=n-a></a>McDermott DF, Drake CG, Sznol M, <i> et al.</i>: Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab. <i>J Clin Oncol.</i> 2015; <b>33</b>(18): 201320. <a target=xrefwindow id=d10e1596 href="http://www.ncbi.nlm.nih.gov/pubmed/25800770">PubMed Abstract </a> | <a target=xrefwindow id=d10e1599 href="http://dx.doi.org/10.1200/JCO.2014.58.1041">Publisher Full Text </a> | <a target=xrefwindow id=d10e1603 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4517051">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727777494"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1612 class=n-a></a>Hammers HJ, Plimack ER, Infante JR, <i> et al.</i>: Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study. <i>J Clin Oncol.</i> 2017; <b>35</b>(34): 38518. <a target=xrefwindow id=d10e1623 href="http://www.ncbi.nlm.nih.gov/pubmed/28678668">PubMed Abstract </a> | <a target=xrefwindow id=d10e1626 href="http://dx.doi.org/10.1200/JCO.2016.72.1985">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727777494">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d10e1639 class=n-a></a>Linch SN, McNamara MJ, Redmond WL: OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal. <i>Front Oncol.</i> 2015; <b>5</b>: 34. <a target=xrefwindow id=d10e1647 href="http://www.ncbi.nlm.nih.gov/pubmed/25763356">PubMed Abstract </a> | <a target=xrefwindow id=d10e1650 href="http://dx.doi.org/10.3389/fonc.2015.00034">Publisher Full Text </a> | <a target=xrefwindow id=d10e1653 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4329814">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d10e1662 class=n-a></a>Pinthus JH, Whelan KF, Gallino D, <i> et al.</i>: Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications. <i>Can Urol Assoc J.</i> 2011; <b>5</b>(4): 27482. <a target=xrefwindow id=d10e1673 href="http://www.ncbi.nlm.nih.gov/pubmed/21801687">PubMed Abstract </a> | <a target=xrefwindow id=d10e1676 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3147044">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726570558"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1685 class=n-a></a>van der Mijn JC, Panka DJ, Geissler AK, <i> et al.</i>: Novel drugs that target the metabolic reprogramming in renal cell cancer. <i>Cancer Metab.</i> 2016; <b>4</b>: 14. <a target=xrefwindow id=d10e1696 href="http://www.ncbi.nlm.nih.gov/pubmed/27418963">PubMed Abstract </a> | <a target=xrefwindow id=d10e1699 href="http://dx.doi.org/10.1186/s40170-016-0154-8">Publisher Full Text </a> | <a target=xrefwindow id=d10e1703 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4944519">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726570558">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727446596"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1716 class=n-a></a>Okazaki A, Gameiro PA, Christodoulou D, <i> et al.</i>: Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and <i>VHL</i>-deficient renal cancers. <i>J Clin Invest.</i> 2017; <b>127</b>(5): 163145. <a target=xrefwindow id=d10e1730 href="http://www.ncbi.nlm.nih.gov/pubmed/28346230">PubMed Abstract </a> | <a target=xrefwindow id=d10e1734 href="http://dx.doi.org/10.1172/JCI87800">Publisher Full Text </a> | <a target=xrefwindow id=d10e1737 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5409089">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727446596">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731980317"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1751 class=n-a></a>Abu Aboud O, Habib SL, Trott J, <i> et al.</i>: Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging. <i>Cancer Res.</i> 2017; <b>77</b>(23): 674658. <a target=xrefwindow id=d10e1762 href="http://www.ncbi.nlm.nih.gov/pubmed/29021138">PubMed Abstract </a> | <a target=xrefwindow id=d10e1765 href="http://dx.doi.org/10.1158/0008-5472.CAN-17-0930">Publisher Full Text </a> | <a target=xrefwindow id=d10e1769 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5791889">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731980317">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d10e1782 class=n-a></a>Meric-Bernstam F, Tannir NM, Mier JW, <i> et al.</i>: Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS), alone and in combination with everolimus (E) in patients (pts) with renal cell cancer (RCC). <i>J Clin Oncol.</i> 2016; <b>34</b>(15_suppl): 4568. <a target=xrefwindow id=d10e1793 href="http://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.4568">Reference Source</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13230956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1802 class=n-a></a>Chan DA, Sutphin PD, Nguyen P, <i> et al.</i>: Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. <i>Sci Transl Med.</i> 2011; <b>3</b>(94): 94ra70. <a target=xrefwindow id=d10e1813 href="http://www.ncbi.nlm.nih.gov/pubmed/21813754">PubMed Abstract </a> | <a target=xrefwindow id=d10e1816 href="http://dx.doi.org/10.1126/scitranslmed.3002394">Publisher Full Text </a> | <a target=xrefwindow id=d10e1820 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3683134">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13230956">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d10e1833 class=n-a></a>Liu Y, Cao Y, Zhang W, <i> et al.</i>: A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth <i>in vitro</i> and <i>in vivo</i>. <i>Mol Cancer Ther.</i> 2012; <b>11</b>(8): 167282. <a target=xrefwindow id=d10e1851 href="http://www.ncbi.nlm.nih.gov/pubmed/22689530">PubMed Abstract </a> | <a target=xrefwindow id=d10e1854 href="http://dx.doi.org/10.1158/1535-7163.MCT-12-0131">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d10e1863 class=n-a></a>WARBURG O: On respiratory impairment in cancer cells. <i>Science.</i> 1956; <b>124</b>(3215): 26970. <a target=xrefwindow id=d10e1871 href="http://www.ncbi.nlm.nih.gov/pubmed/13351639">PubMed Abstract </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d10e1880 class=n-a></a>Clem B, Telang S, Clem A, <i> et al.</i>: Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. <i>Mol Cancer Ther.</i> 2008; <b>7</b>(1): 11020. <a target=xrefwindow id=d10e1891 href="http://www.ncbi.nlm.nih.gov/pubmed/18202014">PubMed Abstract </a> | <a target=xrefwindow id=d10e1894 href="http://dx.doi.org/10.1158/1535-7163.MCT-07-0482">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d10e1904 class=n-a></a>Clem BF, O'Neal J, Tapolsky G, <i> et al.</i>: Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer. <i>Mol Cancer Ther.</i> 2013; <b>12</b>(8): 146170. <a target=xrefwindow id=d10e1915 href="http://www.ncbi.nlm.nih.gov/pubmed/23674815">PubMed Abstract </a> | <a target=xrefwindow id=d10e1918 href="http://dx.doi.org/10.1158/1535-7163.MCT-13-0097">Publisher Full Text </a> | <a target=xrefwindow id=d10e1922 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3742633">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1031718"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1931 class=n-a></a>Papandreou I, Cairns RA, Fontana L, <i> et al.</i>: HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. <i>Cell Metab.</i> 2006; <b>3</b>(3): 18797. <a target=xrefwindow id=d10e1942 href="http://www.ncbi.nlm.nih.gov/pubmed/16517406">PubMed Abstract </a> | <a target=xrefwindow id=d10e1945 href="http://dx.doi.org/10.1016/j.cmet.2006.01.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1031718">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725832242"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10e1958 class=n-a></a>Kinnaird A, Dromparis P, Saleme B, <i> et al.</i>: Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase. <i>Eur Urol.</i> 2016; <b>69</b>(4): 73444. <a target=xrefwindow id=d10e1969 href="http://www.ncbi.nlm.nih.gov/pubmed/26433571">PubMed Abstract </a> | <a target=xrefwindow id=d10e1972 href="http://dx.doi.org/10.1016/j.eururo.2015.09.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725832242">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 12 Mar 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-307.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-307.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Division of Medical Oncology, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA<br/> <p> <div class=margin-bottom> Shahzaib Nabi <br/> <span>Roles: </span> Conceptualization, Project Administration, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Elizabeth R. Kessler <br/> <span>Roles: </span> Conceptualization, Writing  Review & Editing </div> <div class=margin-bottom> Brandon Bernard <br/> <span>Roles: </span> Conceptualization, Writing  Review & Editing </div> <div class=margin-bottom> Thomas W. Flaig <br/> <span>Roles: </span> Conceptualization, Writing  Review & Editing </div> <div class=margin-bottom> Elaine T. Lam <br/> <span>Roles: </span> Conceptualization, Project Administration, Resources, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-307/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 12 Mar 2018, 7:307 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.13179.1">https://doi.org/10.12688/f1000research.13179.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Nabi S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=14298 data-id=13179 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13179.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-307/v1/pdf?article_uuid=d5cea59e-f882-409f-84b9-c52f6def71df" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.13179.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Nabi S, Kessler ER, Bernard B <em>et al.</em> Renal cell carcinoma: a review of biology and pathophysiology [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):307 (<a href="https://doi.org/10.12688/f1000research.13179.1" target=_blank>https://doi.org/10.12688/f1000research.13179.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=13179 id=mobile-track-article-signin-13179 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13179?target=/articles/7-307.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=14298 /> <input name=articleId type=hidden value=13179 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Mehdi Mollapour</strong>, Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>James J. Hsieh</strong>, Molecular Oncology, Department of Medicine, Siteman Cancer Center, Washington University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 12 Mar 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-307.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-307.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=31549-31649></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=31548-31650></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-307/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>12 Mar 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Mehdi Mollapour</strong>, Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>James J. Hsieh</strong>, Molecular Oncology, Department of Medicine, Siteman Cancer Center, Washington University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-307.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-307/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Renal cell carcinoma: a review of biology...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-307/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-307/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-307/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Nabi S et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-307/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-307",
            templates : {
                twitter : "Renal cell carcinoma: a review of biology and pathophysiology. Nabi S et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-307/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Renal cell carcinoma: a review of biology and pathophysiology", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Renal cell carcinoma: a review of biology and pathophysiology", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/13179/14298")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "14298");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "31649": 0,
                           "31650": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "8229859a-844e-4ba6-8a53-9e77f57c315d";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-307.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-307.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-307.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-307.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-307.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>